Caitlin Bernard1, Leping Wan2, Jeffrey F Peipert3, Tessa Madden4. 1. Department of Obstetrics & Gynecology, Indiana University School of Medicine, Indianapolis, Indiana. Electronic address: caitlinbernardmd@gmail.com. 2. Division of Clinical Research, Department of Obstetrics & Gynecology, Washington University in St. Louis School of Medicine, St. Louis, MO. 3. Department of Obstetrics & Gynecology, Indiana University School of Medicine, Indianapolis, Indiana. 4. Division of Family Planning, Department of Obstetrics & Gynecology, Washington University in St. Louis School of Medicine, St. Louis, MO.
Abstract
OBJECTIVE: To investigate whether an early 3-week postpartum visit in addition to the standard 6-week visit increases long-acting reversible contraception (LARC) initiation by 8 weeks postpartum compared to the routine 6-week visit alone. STUDY DESIGN: We enrolled pregnant and immediate postpartum women into a prospective randomized, non-blinded trial comparing a single 6-week postpartum visit (routine care) to two visits at 3 and 6 weeks postpartum (intervention), with initiation of contraception at the 3-week visit, if desired. All participants received structured contraceptive counseling. Participants completed surveys in-person at baseline and at the time of each postpartum visit. A sample size of 200 total participants was needed to detect a 2-fold difference in LARC initiation (20% vs. 40%). RESULTS:Between May 2016 and March 2017, 200 participants enrolled; outcome data are available for 188. The majority of LARC initiation occurred immediately postpartum (25% of the intervention arm and 27% of the routine care arm). By 8 weeks postpartum, 34% of participants in the intervention arm initiated LARC, compared to 41% in the routine care arm (p=.35). Overall contraceptive initiation by 8 weeks was 83% and 84% in the intervention and routine care arms, respectively (p=.79). There was no difference between the arms in the proportion of women who attended at least one postpartum visit (70% vs. 74%, p=.56). CONCLUSION: The addition of a 3-week postpartum visit to routine care does not increase LARC initiation by 8 weeks postpartum. The majority of LARC users desired immediate rather than interval postpartum initiation. CLINICAL TRIAL REGISTRATION: Clinicaltrials.govNCT02769676 IMPLICATIONS: The addition of a 3-week postpartum visit to routine care does not increase LARC or overall contraceptive initiation by 8 weeks postpartum when the option of immediate postpartum placement is available. The majority of LARC users desired immediate rather than interval postpartum initiation.
RCT Entities:
OBJECTIVE: To investigate whether an early 3-week postpartum visit in addition to the standard 6-week visit increases long-acting reversible contraception (LARC) initiation by 8 weeks postpartum compared to the routine 6-week visit alone. STUDY DESIGN: We enrolled pregnant and immediate postpartum women into a prospective randomized, non-blinded trial comparing a single 6-week postpartum visit (routine care) to two visits at 3 and 6 weeks postpartum (intervention), with initiation of contraception at the 3-week visit, if desired. All participants received structured contraceptive counseling. Participants completed surveys in-person at baseline and at the time of each postpartum visit. A sample size of 200 total participants was needed to detect a 2-fold difference in LARC initiation (20% vs. 40%). RESULTS: Between May 2016 and March 2017, 200 participants enrolled; outcome data are available for 188. The majority of LARC initiation occurred immediately postpartum (25% of the intervention arm and 27% of the routine care arm). By 8 weeks postpartum, 34% of participants in the intervention arm initiated LARC, compared to 41% in the routine care arm (p=.35). Overall contraceptive initiation by 8 weeks was 83% and 84% in the intervention and routine care arms, respectively (p=.79). There was no difference between the arms in the proportion of women who attended at least one postpartum visit (70% vs. 74%, p=.56). CONCLUSION: The addition of a 3-week postpartum visit to routine care does not increase LARC initiation by 8 weeks postpartum. The majority of LARC users desired immediate rather than interval postpartum initiation. CLINICAL TRIAL REGISTRATION: Clinicaltrials.govNCT02769676 IMPLICATIONS: The addition of a 3-week postpartum visit to routine care does not increase LARC or overall contraceptive initiation by 8 weeks postpartum when the option of immediate postpartum placement is available. The majority of LARC users desired immediate rather than interval postpartum initiation.
Authors: Maureen K Baldwin; Alison B Edelman; Jeong Y Lim; Mark D Nichols; Paula H Bednarek; Jeffrey T Jensen Journal: Contraception Date: 2015-12-11 Impact factor: 3.375
Authors: Joshua D Dahlke; Eric R Terpstra; Abigail M Ramseyer; Jeanne M Busch; Thomas Rieg; Everett F Magann Journal: Contraception Date: 2011-02-24 Impact factor: 3.375
Authors: William C Livingood; Katryne Lukens Bull; Staci Biegner; Andrew M Kaunitz; LaRonda Howard; Vanessa Jefferson; Pia Julia Geisselmaier; Isabelle Michel; Lori Bilello Journal: F S Rep Date: 2022-02-23